Abbott LaboratoriesABT
What Abbott Laboratories does.
Abbott Laboratories is an Illinois corporation, incorporated in 1900. Abbott’s* principal business is the discovery, development, manufacture, and sale of a broad and diversified line of healthcare products.
On November 19, 2025, Abbott entered into a definitive agreement to acquire Exact Sciences Corporation (Exact Sciences), which is expected to enable Abbott to enter the cancer diagnostics market. The acquisition is subject to customary closing conditions, including the approval of Exact Sciences shareholders and obtaining the required regulatory clearances.
Abbott has four reportable segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices.
Revenue and profit, by fiscal year.
| Fiscal year | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenue | $34.6B | $43.1B | $43.7B | $40.1B | $42.0B | $44.3B |
| Net income | $4.5B | $7.1B | $6.9B | $5.7B | $13.4B | $6.5B |
| Free cash flow | $5.7B | $8.6B | $7.8B | $5.1B | $6.4B | $7.4B |
More on ABT.
- Abbott Laboratories summary
- Abbott Laboratories financial statements
- Abbott Laboratories key metrics
- Abbott Laboratories health scores and style box
- Abbott Laboratories earnings
- Abbott Laboratories dividends
- Abbott Laboratories valuation
- Abbott Laboratories ownership and insiders
- Abbott Laboratories peers
Figures from Abbott Laboratories's filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.